毛囊细胞悬液与表皮细胞悬液联合移植作为难治性白癜风新型手术方法的随机临床试验
这项前瞻性、观察者盲法、阳性对照随机临床试验在三级医院纳入30例稳定期对称性白癜风患者,比较自体非培养表皮细胞悬液(ECS)与ECS联合毛囊细胞悬液(ECS+FCS)的疗效。结果显示ECS+FCS在复色面积(76% vs 57%)、复色速度(48% vs 31%)、颜色匹配(73% vs 61%)及患者满意度方面均优于ECS,黑素细胞干细胞计数及bFGF、SCF表达亦更高。
要点
- ECS+FCS较单用ECS显著提高难治性白癜风复色面积(76% vs 57%,P<.001)。
- 联合移植在复色速度、颜色匹配及患者满意度方面均优于单用ECS。
- ECS+FCS中黑素细胞干细胞计数及bFGF、SCF表达均高于ECS(P<.05)。
核心结论
- ECS+FCS是白癜风手术的一种新方法,可在短期内获得良好至优秀复色及良好颜色匹配,即使对难治性白癜风亦如此。
研究设计与样本
- 前瞻性、观察者盲法、阳性对照随机临床试验,在三级医院门诊开展,2013年10月18日至2016年10月28日招募30例稳定期对称性白癜风患者,采用意向性治疗分析。
主要发现
- ECS+FCS组复色面积76% vs ECS组57%(P<.001);复色速度48% vs 31%(P=.001);颜色匹配73% vs 61%(P<.001)。
- 患者总体评估评分均值(SD)ECS+FCS组23.30(6.89) vs ECS组20.81(6.61),P=.047。
- 黑素细胞干细胞计数ECS+FCS组2% vs ECS组0.5%;碱性成纤维细胞生长因子表达11.8倍、干细胞因子表达6.0倍,均在ECS+FCS悬液中更高(两者P<.05)。
- 74%的病灶(62/84)为难治性白癜风。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Epidermal cell suspension (ECS) and follicular cell suspension (FCS) are successful surgical modalities for the treatment of stable vitiligo. However, repigmentation in generalized and acrofacial vitiligo and over acral or bony sites (eg, elbows, knees, iliac crests, and malleoli), which are difficult to treat, is challenging. OBJECTIVE: To study the efficacy of transplanting a combination of autologous, noncultured ECS and FCS (ECS + FCS) compared with ECS alone in stable vitiligo. DESIGN, SETTING, AND PARTICIPANTS: A prospective, observer-blinded, active-controlled, randomized clinical trial was conducted at a tertiary care hospital, with treatment administered as an outpatient procedure. Thirty participants who had stable vitiligo with symmetrical lesions were recruited between October 18, 2013, and October 28, 2016. All of the lesions were resistant to medical modalities with minimum lesional stability of 1 year. Intent-to-treat analysis was used. INTERVENTIONS: ECS + FCS was prepared by mixing equal amounts (in cell number) of FCS with ECS. After manual dermabrasion, ECS was applied to 1 lesion and ECS + FCS was applied to the anatomically based paired lesion of the same patient. No adjuvant treatment was given. MAIN OUTCOMES AND MEASURES: Patients were followed up at 4, 8, and 16 weeks by a blinded observer and extent of repigmentation, color match, pattern of repigmentation, patient satisfaction and complications were noted. Both the visual and the computerized image analysis methods were used for outcome assessment. Cell suspensions were assessed post hoc for OCT4+ stem cell counts using flow cytometry; expression of stem cell factor and basic fibroblast growth factor was evaluated using quantitative relative messenger RNA expression. RESULTS: Of the 30 patients included in the study, 18 (60%) were women; mean (SD) age was 23.4 (6.4) years. Seventy-four percent of the lesions (62 of 84) were difficult-to-treat vitiligo. ECS + FCS showed superior repigmentation outcomes compared with ECS: extent (76% vs 57%, P < .001), rapidity (48% vs 31%, P = .001), color match (73% vs 61%, P < .001), and patient satisfaction (mean [SD] patient global assessment score, 23.30 [6.89] vs 20.81 [6.61], P = .047). Melanocyte stem cell counts (2% in ECS + FCS vs 0.5% in ECS) as well as expression of basic fibroblast growth factor (11.8-fold) and stem cell factor (6.0-fold) were higher in ECS + FCS suspension (P<.05 for both). CONCLUSIONS AND RELEVANCE: The findings from this study establish ECS + FCS as a novel approach in vitiligo surgery for attaining good to excellent repigmentation in a short period with good color match, even in difficult-to-treat vitiligo. TRIAL REGISTRATION: ctri.nic.in Identifier: CTRI/2017/05/008692.
引用
- Razmi T M, Kumar R, Rani S, et al. Combination of Follicular and Epidermal Cell Suspension as a Novel Surgical Approach in Difficult-to-Treat Vitiligo: A Randomized Clinical Trial. JAMA Dermatol. 2018. PMID: 29387874. doi:10.1001/jamadermatol.2017.5795
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。